Tevogen Bio is driven by a team of highly experienced industry leaders and distinguished scientists with drug development and global product launch experience. Tevogen Bio’s leadership believes that ...

Now, researchers at the Perelman School of Medicine at the University of Pennsylvania have developed a new strategy using sEVs made from natural killer (NK) cells to target death receptor 5 (DR5).

Sources: About ANKTIVA The cytokine interleukin-15 (IL-15) plays a crucial role in the immune system by affecting the development, maintenance, and function of key immune cells—NK and CD8 ...

HB-500 is a next-generation therapeutic vaccine being developed in collaboration with Gilead Sciences, Inc. (Gilead) as a potential component of ...

HB-500 is a next-generation therapeutic vaccine being developed in collaboration with Gilead Sciences, Inc. (Gilead) as a potential component of a curative regimen for human immunodeficiency virus (HI ...

Human T cells were treated with SST, and various parameters including proliferation, cytokine production, and metabolic activities ... BD Bioscience), CD4-APC-Cy7 (RPA-T4, BD Bioscience), CD8-PE-Cy7 ...

Developing effective treatments and understanding how the mechanism of the immune system have always been challenging for ...

Study uncovers a pathogenic subset of memory T-cells that promote tissue inflammation and highlights a potential target for treating nasal polyps and other inflammatory airway diseases. Study ...

is strongly induced in CD8 + T cells in solid cancer, the primary immune cells involved in combating cancer. P4HA1 causes disruptions in energy production within the cells, which leads to weaker ...

According to research by nova one advisor, the global cell and gene therapy market size was valued at $18.13 billion in 2023 ...